Literature DB >> 25270153

Rare case of severe cholangiopathy following critical illness.

Kamal Vijaykant Patel1, Sameer Zaman1, Fuju Chang2, Mark Wilkinson1.   

Abstract

Secondary sclerosing cholangitis is a rare condition caused by disorders directly damaging the biliary tree. We present a case of a 34-year-old man with no pre-existing hepatobiliary disease who developed significant cholestasis and subsequent cholangitis while in the intensive care unit for multiorgan failure secondary to H1N1 influenza A (swine flu). After discharge from the intensive care unit, jaundice, fevers, abdominal pain, pruritus and ongoing cholestasis persisted, consistent with recurrent cholangitis. Secondary sclerosing cholangitis was confirmed by liver biopsy and endoscopic retrograde cholangiopancreatography. This is a case of the recently described syndrome of secondary sclerosing cholangitis following critical illness, with associated severe hypoxic and ischaemic injury. He subsequently developed recognised complications of sclerosing cholangitis, including fat-soluble vitamin deficiencies, recurrent cholangitis and liver fibrosis. To the best of our knowledge, this is the first reported case of secondary sclerosing cholangitis following critical illness in the UK. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25270153      PMCID: PMC4180570          DOI: 10.1136/bcr-2013-202476

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.

Authors:  Gabi I Kirchner; Marcus N Scherer; Aiman Obed; Petra Ruemmele; Reiner Wiest; Matthias Froh; Martin Loss; Hans-Juergen Schlitt; Juergen Schölmerich; Cornelia M Gelbmann
Journal:  Scand J Gastroenterol       Date:  2010-11-30       Impact factor: 2.423

Review 2.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 3.  Hypoxic liver injury and cholestasis in critically ill patients.

Authors:  Thomas Horvatits; Michael Trauner; Valentin Fuhrmann
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

4.  Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.

Authors:  Cornelia M Gelbmann; Petra Rümmele; Monika Wimmer; Ferdinand Hofstädter; Björn Göhlmann; Esther Endlicher; Frank Kullmann; Julia Langgartner; Jürgen Schölmerich
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

Review 5.  Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review.

Authors:  O-nyoung Kwon; Seung Hyun Cho; Chang Keun Park; Sung Hee Mun
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

6.  Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS.

Authors:  Thomas Weig; Mirjam I Schubert; Norbert Gruener; Michael E Dolch; Lorenz Frey; Jens Miller; Thorsten Johnson; Michael Irlbeck
Journal:  Eur J Med Res       Date:  2012-12-22       Impact factor: 2.175

  6 in total
  4 in total

1.  Secondary sclerosing cholangitis in a critically ill patient.

Authors:  Krista E Weiss; Juergen K Willmann; R Brooke Jeffrey; Terry S Desser
Journal:  Quant Imaging Med Surg       Date:  2016-04

2.  Forsaken Foregut: Case Report of Simultaneous Black Esophagus and Ischemic Cholangiopathy.

Authors:  Paul A Cameron; Franzjosef Schweiger
Journal:  Case Rep Med       Date:  2017-04-24

3.  Secondary sclerosing cholangitis following extracorporeal membrane oxygenation for acute respiratory distress in polytrauma.

Authors:  Ruth Tunney; Jennifer Scott; Velauthan Rudralingam; Sue Liong; Varinder S Athwal
Journal:  Clin Case Rep       Date:  2018-08-02

Review 4.  Lung Transplantation for Acute Respiratory Distress Syndrome.

Authors:  Ankit Bharat; Konrad Hoetzenecker
Journal:  Thorac Surg Clin       Date:  2022-01-31       Impact factor: 2.946

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.